nodes	percent_of_prediction	percent_of_DWPC	metapath
Amantadine—ABCB1—Lisinopril—systemic scleroderma	0.0849	0.328	CbGbCtD
Amantadine—ABCB1—Captopril—systemic scleroderma	0.0636	0.246	CbGbCtD
Amantadine—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.05	0.194	CbGbCtD
Amantadine—ABCB1—Prednisone—systemic scleroderma	0.04	0.155	CbGbCtD
Amantadine—ABCB1—Methotrexate—systemic scleroderma	0.0201	0.0776	CbGbCtD
Amantadine—Hyperhidrosis—Leflunomide—systemic scleroderma	0.00132	0.00178	CcSEcCtD
Amantadine—Confusional state—Mycophenolic acid—systemic scleroderma	0.00131	0.00177	CcSEcCtD
Amantadine—Angiopathy—Mycophenolate mofetil—systemic scleroderma	0.00131	0.00177	CcSEcCtD
Amantadine—Body temperature increased—Captopril—systemic scleroderma	0.00131	0.00177	CcSEcCtD
Amantadine—Mediastinal disorder—Mycophenolate mofetil—systemic scleroderma	0.0013	0.00176	CcSEcCtD
Amantadine—Oedema—Mycophenolic acid—systemic scleroderma	0.0013	0.00176	CcSEcCtD
Amantadine—Anorexia—Leflunomide—systemic scleroderma	0.0013	0.00175	CcSEcCtD
Amantadine—Nausea—Pentoxifylline—systemic scleroderma	0.0013	0.00175	CcSEcCtD
Amantadine—Arrhythmia—Mycophenolate mofetil—systemic scleroderma	0.00129	0.00174	CcSEcCtD
Amantadine—Diarrhoea—Mometasone—systemic scleroderma	0.00129	0.00174	CcSEcCtD
Amantadine—Leukopenia—Lisinopril—systemic scleroderma	0.00129	0.00173	CcSEcCtD
Amantadine—Renal failure acute—Methotrexate—systemic scleroderma	0.00128	0.00173	CcSEcCtD
Amantadine—Alopecia—Mycophenolate mofetil—systemic scleroderma	0.00128	0.00172	CcSEcCtD
Amantadine—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.00128	0.00172	CcSEcCtD
Amantadine—Hypotension—Leflunomide—systemic scleroderma	0.00128	0.00172	CcSEcCtD
Amantadine—Tachycardia—Mycophenolic acid—systemic scleroderma	0.00127	0.00171	CcSEcCtD
Amantadine—Palpitations—Lisinopril—systemic scleroderma	0.00127	0.00171	CcSEcCtD
Amantadine—Mental disorder—Mycophenolate mofetil—systemic scleroderma	0.00127	0.00171	CcSEcCtD
Amantadine—Skin disorder—Mycophenolic acid—systemic scleroderma	0.00126	0.00171	CcSEcCtD
Amantadine—Malnutrition—Mycophenolate mofetil—systemic scleroderma	0.00126	0.0017	CcSEcCtD
Amantadine—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.00126	0.0017	CcSEcCtD
Amantadine—Visual disturbance—Methotrexate—systemic scleroderma	0.00125	0.00169	CcSEcCtD
Amantadine—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.00125	0.00168	CcSEcCtD
Amantadine—Anorexia—Mycophenolic acid—systemic scleroderma	0.00124	0.00167	CcSEcCtD
Amantadine—Tension—Mycophenolate mofetil—systemic scleroderma	0.00124	0.00167	CcSEcCtD
Amantadine—Insomnia—Leflunomide—systemic scleroderma	0.00123	0.00166	CcSEcCtD
Amantadine—Paraesthesia—Leflunomide—systemic scleroderma	0.00123	0.00165	CcSEcCtD
Amantadine—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.00122	0.00165	CcSEcCtD
Amantadine—Anxiety—Lisinopril—systemic scleroderma	0.00122	0.00164	CcSEcCtD
Amantadine—Dyspnoea—Leflunomide—systemic scleroderma	0.00122	0.00164	CcSEcCtD
Amantadine—Hypotension—Mycophenolic acid—systemic scleroderma	0.00122	0.00164	CcSEcCtD
Amantadine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.00121	0.00164	CcSEcCtD
Amantadine—Lethargy—Methotrexate—systemic scleroderma	0.00121	0.00163	CcSEcCtD
Amantadine—Dyspepsia—Leflunomide—systemic scleroderma	0.0012	0.00162	CcSEcCtD
Amantadine—Vomiting—Mometasone—systemic scleroderma	0.0012	0.00162	CcSEcCtD
Amantadine—Dry mouth—Lisinopril—systemic scleroderma	0.0012	0.00161	CcSEcCtD
Amantadine—Sweating increased—Prednisone—systemic scleroderma	0.00119	0.00161	CcSEcCtD
Amantadine—Feeling abnormal—Azathioprine—systemic scleroderma	0.00119	0.00161	CcSEcCtD
Amantadine—Rash—Mometasone—systemic scleroderma	0.00119	0.0016	CcSEcCtD
Amantadine—Asthenia—Captopril—systemic scleroderma	0.00119	0.0016	CcSEcCtD
Amantadine—Dermatitis—Mometasone—systemic scleroderma	0.00119	0.0016	CcSEcCtD
Amantadine—Decreased appetite—Leflunomide—systemic scleroderma	0.00119	0.0016	CcSEcCtD
Amantadine—Osteoarthritis—Methotrexate—systemic scleroderma	0.00118	0.0016	CcSEcCtD
Amantadine—Confusional state—Lisinopril—systemic scleroderma	0.00118	0.00159	CcSEcCtD
Amantadine—Headache—Mometasone—systemic scleroderma	0.00118	0.00159	CcSEcCtD
Amantadine—Tremor—Mycophenolate mofetil—systemic scleroderma	0.00118	0.00159	CcSEcCtD
Amantadine—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.00118	0.00159	CcSEcCtD
Amantadine—Insomnia—Mycophenolic acid—systemic scleroderma	0.00118	0.00159	CcSEcCtD
Amantadine—Fatigue—Leflunomide—systemic scleroderma	0.00118	0.00159	CcSEcCtD
Amantadine—Anaphylactic shock—Lisinopril—systemic scleroderma	0.00117	0.00158	CcSEcCtD
Amantadine—Oedema—Lisinopril—systemic scleroderma	0.00117	0.00158	CcSEcCtD
Amantadine—Pruritus—Captopril—systemic scleroderma	0.00117	0.00158	CcSEcCtD
Amantadine—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.00117	0.00158	CcSEcCtD
Amantadine—Constipation—Leflunomide—systemic scleroderma	0.00117	0.00157	CcSEcCtD
Amantadine—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.00116	0.00157	CcSEcCtD
Amantadine—Somnolence—Mycophenolic acid—systemic scleroderma	0.00116	0.00156	CcSEcCtD
Amantadine—Agitation—Mycophenolate mofetil—systemic scleroderma	0.00116	0.00156	CcSEcCtD
Amantadine—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.00115	0.00155	CcSEcCtD
Amantadine—Neutropenia—Prednisone—systemic scleroderma	0.00115	0.00154	CcSEcCtD
Amantadine—Tachycardia—Lisinopril—systemic scleroderma	0.00114	0.00154	CcSEcCtD
Amantadine—Body temperature increased—Azathioprine—systemic scleroderma	0.00114	0.00154	CcSEcCtD
Amantadine—Skin disorder—Lisinopril—systemic scleroderma	0.00114	0.00154	CcSEcCtD
Amantadine—Hyperhidrosis—Lisinopril—systemic scleroderma	0.00113	0.00153	CcSEcCtD
Amantadine—Diarrhoea—Captopril—systemic scleroderma	0.00113	0.00153	CcSEcCtD
Amantadine—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.00113	0.00153	CcSEcCtD
Amantadine—Irritability—Methotrexate—systemic scleroderma	0.00113	0.00152	CcSEcCtD
Amantadine—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.00113	0.00152	CcSEcCtD
Amantadine—Feeling abnormal—Leflunomide—systemic scleroderma	0.00112	0.00152	CcSEcCtD
Amantadine—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.00112	0.00152	CcSEcCtD
Amantadine—Fatigue—Mycophenolic acid—systemic scleroderma	0.00112	0.00151	CcSEcCtD
Amantadine—Nausea—Mometasone—systemic scleroderma	0.00112	0.00151	CcSEcCtD
Amantadine—Anorexia—Lisinopril—systemic scleroderma	0.00112	0.00151	CcSEcCtD
Amantadine—Ataxia—Methotrexate—systemic scleroderma	0.00111	0.0015	CcSEcCtD
Amantadine—Constipation—Mycophenolic acid—systemic scleroderma	0.00111	0.0015	CcSEcCtD
Amantadine—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.00111	0.0015	CcSEcCtD
Amantadine—Hypotension—Lisinopril—systemic scleroderma	0.0011	0.00148	CcSEcCtD
Amantadine—Dizziness—Captopril—systemic scleroderma	0.0011	0.00148	CcSEcCtD
Amantadine—Liver function test abnormal—Methotrexate—systemic scleroderma	0.00109	0.00147	CcSEcCtD
Amantadine—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.00109	0.00147	CcSEcCtD
Amantadine—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.00109	0.00147	CcSEcCtD
Amantadine—Body temperature increased—Leflunomide—systemic scleroderma	0.00108	0.00146	CcSEcCtD
Amantadine—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.00107	0.00145	CcSEcCtD
Amantadine—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.00107	0.00144	CcSEcCtD
Amantadine—Hypersensitivity—Azathioprine—systemic scleroderma	0.00106	0.00144	CcSEcCtD
Amantadine—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.00106	0.00144	CcSEcCtD
Amantadine—Insomnia—Lisinopril—systemic scleroderma	0.00106	0.00143	CcSEcCtD
Amantadine—Paraesthesia—Lisinopril—systemic scleroderma	0.00105	0.00142	CcSEcCtD
Amantadine—Vomiting—Captopril—systemic scleroderma	0.00105	0.00142	CcSEcCtD
Amantadine—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.00105	0.00141	CcSEcCtD
Amantadine—Dyspnoea—Lisinopril—systemic scleroderma	0.00105	0.00141	CcSEcCtD
Amantadine—Rash—Captopril—systemic scleroderma	0.00104	0.00141	CcSEcCtD
Amantadine—Dermatitis—Captopril—systemic scleroderma	0.00104	0.00141	CcSEcCtD
Amantadine—Somnolence—Lisinopril—systemic scleroderma	0.00104	0.00141	CcSEcCtD
Amantadine—Headache—Captopril—systemic scleroderma	0.00104	0.0014	CcSEcCtD
Amantadine—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.00104	0.0014	CcSEcCtD
Amantadine—Dyspepsia—Lisinopril—systemic scleroderma	0.00103	0.00139	CcSEcCtD
Amantadine—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.00103	0.00139	CcSEcCtD
Amantadine—Oedema—Mycophenolate mofetil—systemic scleroderma	0.00103	0.00139	CcSEcCtD
Amantadine—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.00103	0.00139	CcSEcCtD
Amantadine—Decreased appetite—Lisinopril—systemic scleroderma	0.00102	0.00138	CcSEcCtD
Amantadine—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.00101	0.00137	CcSEcCtD
Amantadine—Fatigue—Lisinopril—systemic scleroderma	0.00101	0.00136	CcSEcCtD
Amantadine—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.00101	0.00136	CcSEcCtD
Amantadine—Hypersensitivity—Leflunomide—systemic scleroderma	0.00101	0.00136	CcSEcCtD
Amantadine—Constipation—Lisinopril—systemic scleroderma	0.001	0.00135	CcSEcCtD
Amantadine—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.001	0.00135	CcSEcCtD
Amantadine—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000998	0.00135	CcSEcCtD
Amantadine—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000993	0.00134	CcSEcCtD
Amantadine—Diarrhoea—Azathioprine—systemic scleroderma	0.000989	0.00133	CcSEcCtD
Amantadine—Nausea—Captopril—systemic scleroderma	0.000984	0.00133	CcSEcCtD
Amantadine—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.00098	0.00132	CcSEcCtD
Amantadine—Asthenia—Leflunomide—systemic scleroderma	0.000979	0.00132	CcSEcCtD
Amantadine—Hallucination—Prednisone—systemic scleroderma	0.000975	0.00132	CcSEcCtD
Amantadine—Feeling abnormal—Lisinopril—systemic scleroderma	0.000966	0.0013	CcSEcCtD
Amantadine—Pruritus—Leflunomide—systemic scleroderma	0.000966	0.0013	CcSEcCtD
Amantadine—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.00096	0.0013	CcSEcCtD
Amantadine—Neutropenia—Methotrexate—systemic scleroderma	0.000957	0.00129	CcSEcCtD
Amantadine—Dizziness—Azathioprine—systemic scleroderma	0.000956	0.00129	CcSEcCtD
Amantadine—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.000934	0.00126	CcSEcCtD
Amantadine—Asthenia—Mycophenolic acid—systemic scleroderma	0.000934	0.00126	CcSEcCtD
Amantadine—Diarrhoea—Leflunomide—systemic scleroderma	0.000934	0.00126	CcSEcCtD
Amantadine—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000929	0.00125	CcSEcCtD
Amantadine—Body temperature increased—Lisinopril—systemic scleroderma	0.000927	0.00125	CcSEcCtD
Amantadine—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000923	0.00124	CcSEcCtD
Amantadine—Pruritus—Mycophenolic acid—systemic scleroderma	0.000921	0.00124	CcSEcCtD
Amantadine—Vomiting—Azathioprine—systemic scleroderma	0.000919	0.00124	CcSEcCtD
Amantadine—Eye disorder—Prednisone—systemic scleroderma	0.000916	0.00124	CcSEcCtD
Amantadine—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000916	0.00124	CcSEcCtD
Amantadine—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000914	0.00123	CcSEcCtD
Amantadine—Rash—Azathioprine—systemic scleroderma	0.000911	0.00123	CcSEcCtD
Amantadine—Dermatitis—Azathioprine—systemic scleroderma	0.00091	0.00123	CcSEcCtD
Amantadine—Headache—Azathioprine—systemic scleroderma	0.000905	0.00122	CcSEcCtD
Amantadine—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000905	0.00122	CcSEcCtD
Amantadine—Dizziness—Leflunomide—systemic scleroderma	0.000903	0.00122	CcSEcCtD
Amantadine—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000893	0.0012	CcSEcCtD
Amantadine—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000891	0.0012	CcSEcCtD
Amantadine—Angiopathy—Prednisone—systemic scleroderma	0.00089	0.0012	CcSEcCtD
Amantadine—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000887	0.0012	CcSEcCtD
Amantadine—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000879	0.00119	CcSEcCtD
Amantadine—Arrhythmia—Prednisone—systemic scleroderma	0.000876	0.00118	CcSEcCtD
Amantadine—Vomiting—Leflunomide—systemic scleroderma	0.000868	0.00117	CcSEcCtD
Amantadine—Alopecia—Prednisone—systemic scleroderma	0.000866	0.00117	CcSEcCtD
Amantadine—Hypersensitivity—Lisinopril—systemic scleroderma	0.000864	0.00117	CcSEcCtD
Amantadine—Dizziness—Mycophenolic acid—systemic scleroderma	0.000861	0.00116	CcSEcCtD
Amantadine—Rash—Leflunomide—systemic scleroderma	0.000861	0.00116	CcSEcCtD
Amantadine—Dermatitis—Leflunomide—systemic scleroderma	0.00086	0.00116	CcSEcCtD
Amantadine—Mental disorder—Prednisone—systemic scleroderma	0.000859	0.00116	CcSEcCtD
Amantadine—Nausea—Azathioprine—systemic scleroderma	0.000858	0.00116	CcSEcCtD
Amantadine—Headache—Leflunomide—systemic scleroderma	0.000855	0.00115	CcSEcCtD
Amantadine—Malnutrition—Prednisone—systemic scleroderma	0.000853	0.00115	CcSEcCtD
Amantadine—Agranulocytosis—Methotrexate—systemic scleroderma	0.000852	0.00115	CcSEcCtD
Amantadine—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000847	0.00114	CcSEcCtD
Amantadine—Asthenia—Lisinopril—systemic scleroderma	0.000841	0.00113	CcSEcCtD
Amantadine—Pruritus—Lisinopril—systemic scleroderma	0.00083	0.00112	CcSEcCtD
Amantadine—Vomiting—Mycophenolic acid—systemic scleroderma	0.000828	0.00112	CcSEcCtD
Amantadine—Rash—Mycophenolic acid—systemic scleroderma	0.000821	0.00111	CcSEcCtD
Amantadine—Dermatitis—Mycophenolic acid—systemic scleroderma	0.00082	0.00111	CcSEcCtD
Amantadine—Headache—Mycophenolic acid—systemic scleroderma	0.000816	0.0011	CcSEcCtD
Amantadine—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000812	0.0011	CcSEcCtD
Amantadine—Nausea—Leflunomide—systemic scleroderma	0.000811	0.00109	CcSEcCtD
Amantadine—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000809	0.00109	CcSEcCtD
Amantadine—Vision blurred—Prednisone—systemic scleroderma	0.000804	0.00108	CcSEcCtD
Amantadine—Urethral disorder—Methotrexate—systemic scleroderma	0.000803	0.00108	CcSEcCtD
Amantadine—Diarrhoea—Lisinopril—systemic scleroderma	0.000802	0.00108	CcSEcCtD
Amantadine—Visual impairment—Methotrexate—systemic scleroderma	0.00079	0.00106	CcSEcCtD
Amantadine—Agitation—Prednisone—systemic scleroderma	0.000784	0.00106	CcSEcCtD
Amantadine—Dizziness—Lisinopril—systemic scleroderma	0.000776	0.00105	CcSEcCtD
Amantadine—Nausea—Mycophenolic acid—systemic scleroderma	0.000773	0.00104	CcSEcCtD
Amantadine—Eye disorder—Methotrexate—systemic scleroderma	0.000766	0.00103	CcSEcCtD
Amantadine—Cardiac disorder—Methotrexate—systemic scleroderma	0.00076	0.00103	CcSEcCtD
Amantadine—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000757	0.00102	CcSEcCtD
Amantadine—Vomiting—Lisinopril—systemic scleroderma	0.000746	0.00101	CcSEcCtD
Amantadine—Angiopathy—Methotrexate—systemic scleroderma	0.000743	0.001	CcSEcCtD
Amantadine—Rash—Lisinopril—systemic scleroderma	0.000739	0.000997	CcSEcCtD
Amantadine—Convulsion—Prednisone—systemic scleroderma	0.000739	0.000997	CcSEcCtD
Amantadine—Dermatitis—Lisinopril—systemic scleroderma	0.000739	0.000996	CcSEcCtD
Amantadine—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000738	0.000996	CcSEcCtD
Amantadine—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000737	0.000994	CcSEcCtD
Amantadine—Hypertension—Prednisone—systemic scleroderma	0.000737	0.000994	CcSEcCtD
Amantadine—Headache—Lisinopril—systemic scleroderma	0.000735	0.000991	CcSEcCtD
Amantadine—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000727	0.000981	CcSEcCtD
Amantadine—Anxiety—Prednisone—systemic scleroderma	0.000724	0.000977	CcSEcCtD
Amantadine—Alopecia—Methotrexate—systemic scleroderma	0.000724	0.000977	CcSEcCtD
Amantadine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000722	0.000973	CcSEcCtD
Amantadine—Mental disorder—Methotrexate—systemic scleroderma	0.000718	0.000968	CcSEcCtD
Amantadine—Malnutrition—Methotrexate—systemic scleroderma	0.000713	0.000962	CcSEcCtD
Amantadine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000703	0.000948	CcSEcCtD
Amantadine—Nausea—Lisinopril—systemic scleroderma	0.000697	0.00094	CcSEcCtD
Amantadine—Anaphylactic shock—Prednisone—systemic scleroderma	0.000697	0.000939	CcSEcCtD
Amantadine—Oedema—Prednisone—systemic scleroderma	0.000697	0.000939	CcSEcCtD
Amantadine—Nervous system disorder—Prednisone—systemic scleroderma	0.000683	0.000921	CcSEcCtD
Amantadine—Tachycardia—Prednisone—systemic scleroderma	0.00068	0.000917	CcSEcCtD
Amantadine—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.00068	0.000916	CcSEcCtD
Amantadine—Skin disorder—Prednisone—systemic scleroderma	0.000677	0.000912	CcSEcCtD
Amantadine—Hyperhidrosis—Prednisone—systemic scleroderma	0.000673	0.000908	CcSEcCtD
Amantadine—Vision blurred—Methotrexate—systemic scleroderma	0.000672	0.000907	CcSEcCtD
Amantadine—Anorexia—Prednisone—systemic scleroderma	0.000664	0.000895	CcSEcCtD
Amantadine—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000653	0.000881	CcSEcCtD
Amantadine—Rash—Mycophenolate mofetil—systemic scleroderma	0.000648	0.000874	CcSEcCtD
Amantadine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000647	0.000873	CcSEcCtD
Amantadine—Headache—Mycophenolate mofetil—systemic scleroderma	0.000644	0.000868	CcSEcCtD
Amantadine—Leukopenia—Methotrexate—systemic scleroderma	0.000638	0.000861	CcSEcCtD
Amantadine—Insomnia—Prednisone—systemic scleroderma	0.00063	0.00085	CcSEcCtD
Amantadine—Paraesthesia—Prednisone—systemic scleroderma	0.000625	0.000844	CcSEcCtD
Amantadine—Convulsion—Methotrexate—systemic scleroderma	0.000618	0.000833	CcSEcCtD
Amantadine—Dyspepsia—Prednisone—systemic scleroderma	0.000613	0.000827	CcSEcCtD
Amantadine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.00061	0.000823	CcSEcCtD
Amantadine—Decreased appetite—Prednisone—systemic scleroderma	0.000606	0.000817	CcSEcCtD
Amantadine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000603	0.000813	CcSEcCtD
Amantadine—Fatigue—Prednisone—systemic scleroderma	0.000601	0.00081	CcSEcCtD
Amantadine—Constipation—Prednisone—systemic scleroderma	0.000596	0.000803	CcSEcCtD
Amantadine—Confusional state—Methotrexate—systemic scleroderma	0.000587	0.000792	CcSEcCtD
Amantadine—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000582	0.000785	CcSEcCtD
Amantadine—Feeling abnormal—Prednisone—systemic scleroderma	0.000574	0.000774	CcSEcCtD
Amantadine—Nervous system disorder—Methotrexate—systemic scleroderma	0.000571	0.00077	CcSEcCtD
Amantadine—Skin disorder—Methotrexate—systemic scleroderma	0.000565	0.000763	CcSEcCtD
Amantadine—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000563	0.000759	CcSEcCtD
Amantadine—Anorexia—Methotrexate—systemic scleroderma	0.000555	0.000748	CcSEcCtD
Amantadine—Body temperature increased—Prednisone—systemic scleroderma	0.000551	0.000743	CcSEcCtD
Amantadine—Hypotension—Methotrexate—systemic scleroderma	0.000544	0.000734	CcSEcCtD
Amantadine—Insomnia—Methotrexate—systemic scleroderma	0.000527	0.00071	CcSEcCtD
Amantadine—Paraesthesia—Methotrexate—systemic scleroderma	0.000523	0.000705	CcSEcCtD
Amantadine—Dyspnoea—Methotrexate—systemic scleroderma	0.000519	0.0007	CcSEcCtD
Amantadine—Somnolence—Methotrexate—systemic scleroderma	0.000518	0.000698	CcSEcCtD
Amantadine—Hypersensitivity—Prednisone—systemic scleroderma	0.000513	0.000692	CcSEcCtD
Amantadine—Dyspepsia—Methotrexate—systemic scleroderma	0.000512	0.000691	CcSEcCtD
Amantadine—Decreased appetite—Methotrexate—systemic scleroderma	0.000506	0.000682	CcSEcCtD
Amantadine—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000503	0.000678	CcSEcCtD
Amantadine—Fatigue—Methotrexate—systemic scleroderma	0.000502	0.000677	CcSEcCtD
Amantadine—Asthenia—Prednisone—systemic scleroderma	0.0005	0.000674	CcSEcCtD
Amantadine—Pruritus—Prednisone—systemic scleroderma	0.000493	0.000665	CcSEcCtD
Amantadine—Feeling abnormal—Methotrexate—systemic scleroderma	0.00048	0.000647	CcSEcCtD
Amantadine—Diarrhoea—Prednisone—systemic scleroderma	0.000477	0.000643	CcSEcCtD
Amantadine—Dizziness—Prednisone—systemic scleroderma	0.000461	0.000621	CcSEcCtD
Amantadine—Body temperature increased—Methotrexate—systemic scleroderma	0.00046	0.000621	CcSEcCtD
Amantadine—Vomiting—Prednisone—systemic scleroderma	0.000443	0.000597	CcSEcCtD
Amantadine—Rash—Prednisone—systemic scleroderma	0.000439	0.000592	CcSEcCtD
Amantadine—Dermatitis—Prednisone—systemic scleroderma	0.000439	0.000592	CcSEcCtD
Amantadine—Headache—Prednisone—systemic scleroderma	0.000436	0.000589	CcSEcCtD
Amantadine—Hypersensitivity—Methotrexate—systemic scleroderma	0.000429	0.000578	CcSEcCtD
Amantadine—Asthenia—Methotrexate—systemic scleroderma	0.000418	0.000563	CcSEcCtD
Amantadine—Nausea—Prednisone—systemic scleroderma	0.000414	0.000558	CcSEcCtD
Amantadine—Pruritus—Methotrexate—systemic scleroderma	0.000412	0.000555	CcSEcCtD
Amantadine—Diarrhoea—Methotrexate—systemic scleroderma	0.000398	0.000537	CcSEcCtD
Amantadine—Dizziness—Methotrexate—systemic scleroderma	0.000385	0.000519	CcSEcCtD
Amantadine—Vomiting—Methotrexate—systemic scleroderma	0.00037	0.000499	CcSEcCtD
Amantadine—Rash—Methotrexate—systemic scleroderma	0.000367	0.000495	CcSEcCtD
Amantadine—Dermatitis—Methotrexate—systemic scleroderma	0.000367	0.000495	CcSEcCtD
Amantadine—Headache—Methotrexate—systemic scleroderma	0.000365	0.000492	CcSEcCtD
Amantadine—Nausea—Methotrexate—systemic scleroderma	0.000346	0.000466	CcSEcCtD
